Month: September 2012

Johns Hopkins study suggests the commonly prescribed anti-retroviral drug efavirenz attacks brain cells

Popular HIV drug may cause memory declines Johns Hopkins study suggests the commonly prescribed anti-retroviral drug efavirenz attacks brain cells The way the body metabolizes a commonly prescribed anti-retroviral drug that is used long term by patients infected with HIV may contribute to cognitive impairment by damaging nerve cells, a new Johns Hopkins research suggests. …

Johns Hopkins study suggests the commonly prescribed anti-retroviral drug efavirenz attacks brain cells Read More »

HIV-associated fatigue in the era of highly active antiretroviral therapy: novel biological mechanisms?

I am convinced that our mitochondria are affected even after years off Zerit, DDI or AZT. Mitochondrial dysfunction has been widely reported with D drugs (D4T, DDI) and AZT and has been linked to lipoatrophy and metabolic problems.  But I think what we ignore is the permanent effects on the mitochondria even after years of stopping those drugs.   Although mitochondria DNA in fat and muscle …

HIV-associated fatigue in the era of highly active antiretroviral therapy: novel biological mechanisms? Read More »

FDA approved Jak inhibitors and their potential use in HIV – Interview with Dr Raymond Schinazi

As part of my work as a cure and salvage treatment activist, I am constantly searching for treatment options that could serve two purposes: existing medications that could help patients with multidrug resistance and at the same time be used as an approach to cure HIV.  Since my non profit (Program for Wellness Restoration) has …

FDA approved Jak inhibitors and their potential use in HIV – Interview with Dr Raymond Schinazi Read More »

Scroll to Top